Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q2 EPS by 54c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q2 EPS of ($0.59), $0.54 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
• EigenQ and Silicon Valley Acquisition file S-4 for merger
• Anthropic Fy25 Gaap Net Loss Expands To $41.97 Bln Vs $8.31 Bln In Fy24, Prospectus Shows - Reuters